+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Contrast Agents/Media Global Market - Forecast to 2025

  • ID: 4655302
  • Report
  • Region: Global
  • 414 Pages +
  • IQ4I Research & Consultancy Pvt. Ltd
UP TO OFF
until Dec 31st 2019
1 of 4

FEATURED COMPANIES

  • Alzeca Biosciences, Inc.
  • Diahan Pharm. Co. Ltd.
  • Fujipharma Co. Ltd
  • Harmony Life Sciences
  • Lantheus Medical Imaging
  • Nano-Therapeutics
  • MORE

Contrast Agents/Media are substances that improve the visibility of specific organs, tissues or blood vessels and help in diagnostic imaging and interventional procedures of a condition using medical imaging tools. These substances are introduced by swallowing or injection into a specific area of the body and are absorbed or excreted through urine or bowel movements. Contrast Agents used are usually Iodine based, Gadolinium-based, Microbubble based contrast agent and other which include iron-based and barium-based contrast agents. Iodine-based and barium-sulfate contrast agents are used in X-ray and computed tomography (CT) imaging exams wherein the presence of Iodine-based and Barium-sulfate contrast materials at a specific area of the body will block or limit the ability of X-rays to pass through and change their state of appearance on X-ray or CT images. Gadolinium-based contrast agents are preferred in MRI (Magnetic Resonance Imaging) scan in order to improve the clarity of the images of the body’s internal structures. Microbubbles based contrast media is used during ultrasound scans wherein the microbubbles present in suspension strongly interact with the ultrasound beam and easily detectable by ultrasound imaging systems.

As estimated by this research, the contrast agent global market expected to reach $6,879.0 million by 2025. The increase in diagnostic imaging procedures and interventional imaging procedures, increase in incidence and prevalence of disease conditions, increasing in aging population, expansion in indications of contrast media, growth of medical imaging technologies in emerging market, increasing research activities for contrast agents, and favourable reimbursements are driving the market growth. However, adverse effects related to contrast agents and shortage of radiologists is restraining the market growth. Stringent regulations and availability of alternative products are hampering the market expansion.

The contrast agent global market by molecule is segmented into Iodine based [Ionic (Monomeric and Dimeric), Non-Ionic (Monomeric and Dimeric)], Gadolinium-based contrast agents [Macrocyclic (Ionic and Non-Ionic), Linear (Ionic and Non-Ionic)], microbubble-based contrast agent and others which include Barium, iron and dyes. Iodine-based contrast agent market held the largest market share in 2018 and microbubble segment is growing at high double digit CAGR from 2018 to 2025 due to expansion in disease indications.

Innovations in contrast agents are taking place in the areas of packaging, the development of bulk, multi-dose containers, and polymer containers. For instance, FDA approved Isovue (iopamidol injection) Imaging Bulk Package (IBP) (developed by Bracco) which is a specific combination multi-patient, multi-dose compliant contrast medium for point-of-care use in the computed tomography (CT) suite. Increase in research activities for contrast which is supported by funding from different institutes. For instance, Ferric Contrast Company received $225,000 for a Phase I Small Business Technology Transfer (STTR) fund in 2017 in for developing iron-based contrast agents for magnetic resonance imaging (MRI) which is an alternative to the Gadolinium complexes that have traditionally been employed in MRI. Likewise, Inlighta Biosciences LLC received a $2 million grant from the National Cancer Institute in 2017 for development of an improved MRI contrast agent, i.e. ProCA32, a next-generation MRI contrast agents that could be utilized for early detection of primary and metastasized liver cancers. The research is done through collaboration between Inlighta Biosciences, Georgia State University, and Emory University. The funding is used in validation of ProCA32 and used for toxicology a study which is required to support an application to the FDA for human clinical trials.

The research on contrast agents market involved both widespread secondary and primary research. The secondary research was carried out on company websites, annual reports, SEC filings, diagnostic associations, articles, press releases, and journals to identify and collect both the qualitative and quantitative data related to contrast agents. The primary sources were experts from the supply side such as CEOs, directors, international/regional marketing managers and marketing executives. From the demand side, radiologists, hospitals, research laboratory heads, and purchase managers. All the primary sources were interviewed to acquire and verify critical qualitative and quantitative information and also to assess the future forecast of all the segments of the contrast agents market. Along with these, additional information was extracted about the key players in this industry with their market revenues, products and developments. The factors responsible for the growth and restriction of the contrast agents/Media market along with the future opportunities were also determined through secondary research and verified through primary sources.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alzeca Biosciences, Inc.
  • Diahan Pharm. Co. Ltd.
  • Fujipharma Co. Ltd
  • Harmony Life Sciences
  • Lantheus Medical Imaging
  • Nano-Therapeutics
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Report Scope
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Crackdown And Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points From Secondary Sources
2.6.6 Key Data Points From Primary Sources
2.6.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Increasing Demand For Diagnostic And Interventional Radiology Procedures
3.3.1.2 Increase In Incidence And Prevalence Of Disease Conditions
3.3.1.3 Increase In Aging Population
3.3.1.4 Expansion In Indications Of Contrast Media Market
3.3.1.5 The Growth Of Medical Imaging Technologies In Emerging Markets
3.3.1.6 Increasing Research Activities For Contrast Agents
3.3.1.7 Favorable Reimbursement
3.3.2 Restraints And Threats
3.3.2.1 Side Effect Associated With Contrast Agents.
3.3.2.2 Shortage Of Radiologist.
3.3.2.3 Availability Of Alternative Products
3.3.2.4 Stringent Regulations For Contrast Agents.
3.4 Regulatory Guidelines
3.4.1 United States
3.4.2 Europe
3.4.3 China
3.4.4 Japan
3.4.5 India
3.5 Reimbursement Scenario
3.5.1 Reimbursement Table
3.6 Upcoming Technology
3.7 Clinical Trials
3.8 Patent Trends
3.9 Supply Chain Analysis
3.10 Porter's Five Force Analysis
3.10.1 Threat Of New Entrants
3.10.2 Threat Of Substitutes
3.10.3 Bargaining Power Of Suppliers
3.10.4 Bargaining Power Of Buyers
3.10.5 Rivalry Among Existing Competitors
3.11 Market Share Analysis By Major Players
3.11.1 Contrast Agents Global Market
3.11.2 X-Ray/Ct Contrast Agents Market
3.11.3 MRI Contrast Agents Market
3.11.4 Ultrasound Based Contrast Agents Market
3.12 Contrast Agents Global Consumption

4 Contrast Agents Global Market, By Molecule
4.1 Introduction
4.2 Iodine Based Contrast Media
4.2.1 Iodine Based Ionic Contrast Media
4.2.1.1 Monomers
4.2.1.2 Dimer
4.2.2 Iodine Based Non-Ionic Contrast Media
4.2.2.1 Monomer
4.2.2.2 Dimer
4.3 Gadolinium-Based Contrast Media
4.3.1 Macrocyclic
4.3.1.1 Ionic
4.3.1.2 Non-Ionic
4.3.2 Linear
4.3.2.1 Ionic
4.3.2.2 Non-Ionic
4.4 Microbubble Based Contrast Media
4.5 Other Contrast Media

5 Contrast Agents Global Market, By Modality
5.1 Introduction
5.2 X-Ray/Computed Tomography (CT)
5.3 Magnetic Resonance Imaging (MRI)
5.4 Ultrasound

6 Contrast Agents Global Market, By Application
6.1 Introduction
6.2 Cardiovascular
6.3 Cancer
6.4 Gastrointestinal
6.5 Musculoskeletal
6.6 Neurology
6.7 Nephrology
6.8 Obstetrics And Gynecology
6.9 Urology
6.10 Others

7 Contrast Agents Global Market, By Route Of Administration
7.1 Introduction
7.2 Intravascular
7.3 Oral
7.4 Rectal
7.5 Others

8 Contrast Agents Global Market, By Imaging
8.1 Introduction
8.2 Diagnostic Imaging
8.3 Interventional Imaging

9 Contrast Agents Global Market, By End-Users
9.1 Introduction
9.2 Hospital
9.3 Diagnostic & Ambulatory Surgical Centers
9.4 Other End-User

10 Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 The U.S.
10.2.2 Others
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Others
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 Korea
10.4.4 Others
10.5 Rest Of The World
10.5.1 Brazil
10.5.2 Rest Of Latin America
10.5.3 Middle East And Others

11 Competitive Landscape
11.1 Introduction
11.2 Approvals
11.3 Other Key Development
11.4 Collaboration
11.5 Partnership
11.6 Agreement
11.7 New Product Launch

12 Major Player Profiles
12.1 Bayer Group
12.1.1 Overview
12.1.2 Financials
12.1.3 Product Portfolio
12.1.4 Key Developments
12.1.5 Business Strategy
12.1.6 SWOT Analysis
12.2 Beijing Beilu Pharmaceutical Co., Ltd
12.2.1 Overview
12.2.2 Financials
12.2.3 Product Portfolio
12.2.4 Key Developments
12.2.5 Business Strategy
12.2.6 SWOT Analysis
12.3 Bracco Group
12.3.1 Overview
12.3.2 Financials
12.3.3 Product Portfolio
12.3.4 Key Developments
12.3.5 Business Strategy
12.3.6 SWOT Analysis
12.4 Dongkook Life Science
12.4.1 Overview
12.4.2 Financials
12.4.3 Product Portfolio
12.4.4 Key Developments
12.4.5 Business Strategy
12.4.6 SWOT Analysis
12.5 Fujifilm Holdings Corporation
12.5.1 Overview
12.5.2 Financials
12.5.3 Product Portfolio
12.5.4 Key Developments
12.5.5 Business Strategy
12.5.6 SWOT Analysis
12.6 Fujipharma Co Ltd
12.6.1 Overview
12.6.2 Financials
12.6.3 Product Portfolio
12.6.4 Key Developments
12.6.5 Business Strategy
12.6.6 SWOT Analysis
12.7 GE Company (GE Healthcare)
12.7.1 Overview
12.7.2 Financials
12.7.3 Product Portfolio
12.7.4 Key Developments
12.7.5 Business Strategy
12.7.6 SWOT Analysis
12.8 Guerbet
12.8.1 Overview
12.8.2 Financials
12.8.3 Product Portfolio
12.8.4 Key Developments
12.8.5 Business Strategy
12.8.6 SWOT Analysis
12.9 Lantheus Medical Imaging Inc.
12.9.1 Overview
12.9.2 Financials
12.9.3 Product Portfolio
12.9.4 Key Developments
12.9.5 Business Strategy
12.9.6 SWOT Analysis
12.10 Sanochemia Pharmaceutical Ag
12.10.1 Overview
12.10.2 Financials
12.10.3 Product Portfolio
12.10.4 Key Developments
12.10.5 Business Strategy
12.10.6 SWOT Analysis
12.11 Taejoon Pharm Co., Ltd
12.11.1 Overview
12.11.2 Financials
12.11.3 Product Portfolio
12.11.4 Key Developments
12.11.5 Business Strategy
12.11.6 SWOT Analysis

List of Tables
Table 1 Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 2 MRI Contrast Agent Global Consumption, (2017-2025) (L)
Table 3 X-Ray/Ct Contrast Agents Global Consumption, (2017-2025) (L)
Table 4 Contrast Agents Global Market Revenue, By Molecule, (2017-2025) ($Mn)
Table 5 Iodine Based Contrast Agents Global Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 6 Iodine Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 7 Iodine Based Ionic Contrast Agents Global Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 8 Iodine Based Ionic Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 9 Iodine Based Ionic Monomer Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 10 Iodine Based Ionic Dimer Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 11 Iodine Based Non-Ionic Contrast Agents Global Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 12 Iodine Based Non-Ionic Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 13 Iodine Based Non-Ionic Monomer Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 14 Iodine Based Non-Ionic Dimer Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 15 Gadolinium-Based Contrast Agents Global Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 16 Gadolinium-Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 17 Macrocyclic Gadolinium-Based Contrast Agents Global Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 18 Macrocyclic Gadolinium-Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 19 Macrocyclic Ionic Gadolinium-Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 20 Macrocyclic Non-Ionic Gadolinium-Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 21 Linear Gadolinium-Based Contrast Agents Global Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 22 Linear Gadolinium-Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 23 Linear Ionic Gadolinium-Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 24 Linear Non-Ionic Gadolinium-Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 25 Microbubble Based Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 26 Other Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 27 Contrast Agents Global Market Revenue, By Modality, (2017-2025) ($Mn)
Table 28 X-Ray/Ct Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 29 Magnetic Resonance Imaging Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 30 Ultrasound Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 31 Contrast Agents Global Market Revenue, By Application, (2017-2025) ($Mn)
Table 32 Cardiovascular Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 33 Cancer Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 34 Gastrointestinal Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 35 Musculoskeletal Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 36 Neurology Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 37 Nephrology Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 38 Obstetrics And Gynecology Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 39 Urology Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 40 Other Applications Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 41 Contrast Agents Global Market Revenue, By Route Of Administration, (2017-2025) ($Mn)
Table 42 Intravascular Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 43 Oral Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 44 Rectal Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 45 Other Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 46 Contrast Agents Global Market Revenue, By Imaging, (2017-2025) ($Mn)
Table 47 Diagnostic Imaging Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 48 Interventional Imaging Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 49 Contrast Agents Global Market Revenue, By End-Users, (2017-2025) ($Mn)
Table 50 Contrast Agents Hospital Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 51 Contrast Agents Diagnostic & Ambulatory Surgical Center Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 52 Other End-Users Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 53 Contrast Agents Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 54 North America Contrast Agents Market Revenue, By Molecule, (2017-2025) ($Mn)
Table 55 North America Iodine Based Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 56 North America Iodine Based Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 57 North America Iodine Based Non-Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 58 North America Gadolinium-Based Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 59 North America Macrocyclic Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 60 North America Linear Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 61 North America Contrast Agents Market Revenue, By Modality, (2017-2025) ($Mn)
Table 62 North America Contrast Agents Market Revenue, By Application, (2017-2025) ($Mn)
Table 63 North America Contrast Agents Market Revenue, By Route Of Administration, (2017-2025) ($Mn)
Table 64 North America Contrast Agents Market Revenue, By Imaging, (2017-2025) ($Mn)
Table 65 North America Contrast Agents Market Revenue, By End-User, (2017-2025) ($Mn)
Table 66 North America Contrast Agents Global Market Revenue, By Country, (2017-2025) ($Mn)
Table 67 Europe Contrast Agents Market Revenue, By Molecule, (2017-2025) ($Mn)
Table 68 Europe Iodine Based Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 69 Europe Iodine Based Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 70 Europe Iodine Based Non-Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 71 Europe Gadolinium-Based Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 72 Europe Macrocyclic Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 73 Europe Linear Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 74 Europe Contrast Agents Market Revenue, By Modality, (2017-2025) ($Mn)
Table 75 Europe Contrast Agents Market Revenue, By Application, (2017-2025) ($Mn)
Table 76 Europe Contrast Agents Market Revenue, By Route Of Administration, (2017-2025) ($Mn)
Table 77 Europe Contrast Agents Market Revenue, By Imaging, (2017-2025) ($Mn)
Table 78 Europe Contrast Agents Market Revenue, By End-User, (2017-2025) ($Mn)
Table 79 Europe Contrast Agents Global Market Revenue, By Country, (2017-2025) ($Mn)
Table 80 Asia-Pacific Contrast Agents Market Revenue, By Molecule, (2017-2025) ($Mn)
Table 81 Asia-Pacific Iodine Based Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 82 Asia-Pacific Iodine Based Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 83 Asia-Pacific Iodine Based Non-Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 84 Asia-Pacific Gadolinium-Based Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 85 Asia-Pacific Macrocyclic Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 86 Asia-Pacific Linear Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 87 Asia-Pacific Contrast Agents Market Revenue, By Modality, (2017-2025) ($Mn)
Table 88 Asia-Pacific Contrast Agents Market Revenue, By Application, (2017-2025) ($Mn)
Table 89 Asia-Pacific Contrast Agents Market Revenue, By Route Of Administration, (2017-2025) ($Mn)
Table 90 Asia-Pacific Contrast Agents Market Revenue, By Imaging, (2017-2025) ($Mn)
Table 91 Asia-Pacific Contrast Agents Market Revenue, By End-User, (2017-2025) ($Mn)
Table 92 Asia-Pacific Contrast Agents Global Market Revenue, By Country, (2017-2025) ($Mn)
Table 93 Rest Of The World Contrast Agents Market Revenue, By Molecule, (2017-2025) ($Mn)
Table 94 Rest Of The World Iodine Based Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 95 Rest Of The World Iodine Based Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 96 Rest Of The World Iodine Based Non-Ionic Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 97 Rest Of The World Gadolinium-Based Contrast Agents Market Revenue, By Chemical Structure, (2017-2025) ($Mn)
Table 98 Rest Of The World Macrocyclic Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 99 Rest Of The World Linear Contrast Agents Market Revenue, By Ionicity, (2017-2025) ($Mn)
Table 100 Rest Of The World Contrast Agents Market Revenue, By Modality, (2017-2025) ($Mn)
Table 101 Rest Of The World Contrast Agents Market Revenue, By Application, (2017-2025) ($Mn)
Table 102 Rest Of The World Contrast Agents Market Revenue, By Route Of Administration, (2017-2025) ($Mn)
Table 103 Rest Of The World Contrast Agents Market Revenue, By Imaging, (2017-2025) ($Mn)
Table 104 Rest Of The World Contrast Agents Market Revenue, By End-User, (2017-2025) ($Mn)
Table 105 Rest Of The World Contrast Agents Global Market Revenue, By Country, (2017-2025) ($Mn)
Table 106 Approvals (2016-2018)
Table 107 Other Key Development, (2016-2018)
Table 108 Collaboration, (2016-2018)
Table 109 Partnership, (2016-2018)
Table 110 Agreement, (2016-2018)
Table 111 New Product Launch, (2016-2018)
Table 112 Bayer Group: Total Revenue And R&D Expenses (2016-2018) ($Mn)
Table 113 Bayer Group: Total Revenue, By Segments (2016-2018) ($Mn)
Table 114 Bayer Group: Total Revenue, By Geography (2016-2018) ($Mn)
Table 115 Fujifilm Holding Corporation: Total Revenue And R&D Expenses, (2016 – 2018) ($Mn)
Table 116 Fujifilm Holding Corporation: Total Revenue, By Segments (2016-2018) ($Mn)
Table 117 Fujifilm Holding Corporation: Total Revenue, By Geography (2016 – 2018) ($Mn)
Table 118 Fujipharma Co Ltd: Total Revenue And R&D Expenses, (2016–2018) ($Mn)
Table 119 Fujipharma Co Ltd: Total Revenue, By Segments (2016-2018) ($Mn)
Table 120 GE Company: Total Revenue And R&D Expenses (2016 – 2018) ($Mn)
Table 121 GE Company: Total Revenue, By Segments (2016-2018) ($Mn)
Table 122 GE Company: Total Revenue, By Geography (2016 –2018) ($Mn)
Table 123 Guerbet: Total Revenue And R&D Expenses, (2015-2017) ($Mn)
Table 124 Guerbet: Segmental Revenue (2015-2017) ($Mn)
Table 125 Guerbet: Geographic Revenue (2015-2017) ($Mn)
Table 126 Lantheus Medical Imaging Inc.: Total Revenue And R&D Expenses, (2016-2018) ($Mn)
Table 127 Lantheus Medical Imaging Inc.: Total Revenue, By Products (2016-2018) ($Mn)
Table 128 Lantheus Medical Imaging Inc.: Total Revenue, By Geography (2016-2018) ($Mn)
Table 129 Sanochemia Pharmaceutical Ag: Total Revenue And R&D Expenses (2016-2018) ($Mn)
Table 130 Sanochemia Pharmaceutical Ag: Total Revenue, By Segments (2016-2018) ($Mn)

List of Figures
Figure 1 Contrast Agents Global Market Share And Revenue, By Region, (2017-2025) ($Mn), 2018 (%)
Figure 2 Research Methodology: Contrast Agents Global Market
Figure 3 Contrast Agents Global Market: Top-Down And Bottom-Up Approach
Figure 4 Contrast Agents Global Market: Forecasting Model
Figure 5 Contrast Agents Global Market: Market Crackdown And Data Triangulation
Figure 6 Contrast Agents Global Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 Contrast Agents Global Market: Patent Filing By Major Players (2013–2018)
Figure 9 Contrast Agents Global Market: Supply Chain Analysis
Figure 10 Contrast Agents Market: Porter’S Analysis
Figure 11 Contrast Agents Global Market Share Analysis, By Key Players, 2018 (%)
Figure 12 X-Ray/Ct Contrast Agents Market: Major Player Analysis (2018) (%)
Figure 13 MRI Contrast Agents Market: Major Player Analysis (2018) (%)
Figure 14 Ultrasound Based Contrast Agents: Major Player Analysis (2018) (%)
Figure 15 Regional And Countrywise Consumption Of MRI Contrast Agents In Share And Liters: (2018)(%)(L)
Figure 16 Regional And Countrywise Consumption Of X-Ray/Ct Contrast Agents In Share And Liters: (2018) (%) (L)
Figure 17 Contrast Agents Global Market Share, By Molecule (2018 V/S 2025) (%)
Figure 18 Iodine Based Contrast Agents Global Market Share, By Ionicity (2018 V/S 2025) (%)
Figure 19 Iodine Based Ionic Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 20 Iodine Based Ionic Monomer Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 21 Iodine Based Non-Ionic Contrast Agents Global Market Share, By Chemical Structure (2018 V/S 2025) (%)
Figure 22 Iodine Based Non-Ionic Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 23 Iodine Based Non-Ionic Monomer Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 24 Gadolinium-Based Contrast Agents Global Market Revenue, By Chemical Structure (2017-2025) ($Mn)
Figure 25 Gadolinium-Based Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 26 Linear Gadolinium-Based Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 27 Microbubble Based Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 28 Other Contrast Agents Global Market Share, By Region (2018 V/S 2025) (%)
Figure 29 Contrast Agents Global Market Revenue, By Modality (2017-2025) ($Mn)
Figure 30 Contrast Agents Global Market Share, By Application (2018) (%)
Figure 31 Cardiovascular Global Market Share, By Region (2018 V/S 2025) (%)
Figure 32 Gastrointestinal Global Market Share, By Region (2018 V/S 2025) (%)
Figure 33 Musculoskeletal Global Market Share, By Region (2018 V/S 2025) (%)
Figure 34 Nephrology Global Market Share, By Region (2018 V/S 2025) (%)
Figure 35 Obstetrics And Gynecology Global Market Share, By Region (2018 V/S 2025) (%)
Figure 36 Urology Global Market Share, By Region (2018 V/S 2025) (%)
Figure 37 Other Applications Global Market Share, By Region (2018 V/S 2025) (%)
Figure 38 Contrast Agents Global Market Revenue, By Route Of Administration (2018) ($Mn)
Figure 39 Intravascular Global Market Share, By Region (2018 V/S 2025) (%)
Figure 40 Oral Global Market Revenue, By Region (2018-2025) ($Mn)
Figure 41 Rectal Global Market Revenue, By Region (2017-2025) ($Mn)
Figure 42 Other Global Market Revenue, By Region (2017-2025) ($Mn)
Figure 43 Contrast Agents Global Market Share, By Imaging (2018 V/S 2025) (%)
Figure 44 Diagnostic Imaging Global Market Share, By Region (2018 V/S 2025) (%)
Figure 45 Interventional Imaging Procedural Share (%)
Figure 46 Contrast Agents Global Market Share, By End-Users, (2018 V/S 2025) (%)
Figure 47 Hospital Global Market Share, By End-Users, (2018 V/S 2025) (%)
Figure 48 Diagnostic & Ambulatory Surgical Center Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 49 Other End-User Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 50 Contrast Agents Global Market Revenue, By Region (2017-2025) ($Mn), Cagr (%)
Figure 51 Contrast Agents Global Market Share, By Region And Country (2018) (%)
Figure 52 North America Contrast Agents Market Share, By Molecule And Iodine Based Contrast Agents Market Share By Ionicity, (2018 V/S 2025) (%)
Figure 53 North America Iodine Based Ionic And Non-Ionic Contrast Agents Market Share By Chemical Structure, (2018 V/S 2025) (%)
Figure 54 North America Gadolinium-Based Contrast Agents Market Share, By Chemical Structure, (2018 V/S 2025) (%) And Macrocyclic, Linear Contrast Agents Market Revenue, By Ionicity, (2018 V/S 2025) ($Mn)
Figure 55 North America Contrast Agents Market Share, By Modality, And Contrast Agents Market Share, By Imaging, (2018 V/S 2025) (%)
Figure 56 North America Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 57 North America Contrast Agents Market Share, By Route Of Administration And End-User, (2018 V/S 2025) (%)
Figure 58 North America Contrast Agents Market Share, By Country, (2018 V/S 2025) (%)
Figure 59 U.S. Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 60 U.S. Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 61 U.S. Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 62 U.S. Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 63 Other North American Countries Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 64 Other North American Countries Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 65 Other North American Countries Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 66 Other North American Countries Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 67 Europe Contrast Agents Market Share, By Molecule And Iodine Based Contrast Agents Market Share By Ionicity, (2018 V/S 2025) (%)
Figure 68 Europe Iodine Based Ionic And Non-Ionic Contrast Agents Market Share By Chemical Structure, (2018 V/S 2025) (%)
Figure 69 Europe Gadolinium-Based Contrast Agents Market Share, By Chemical Structure, (2018 V/S 2025) (%) And Macrocyclic, Linear Contrast Agents Market Revenue, By Ionicity, (2018 V/S 2025) ($Mn)
Figure 70 Europe Contrast Agents Market Share, By Modality, And Contrast Agents Market Share, By Imaging, (2018 V/S 2025) (%)
Figure 71 Europe Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 72 Europe Contrast Agents Market Share, By Route Of Administration And End-User, (2018 V/S 2025) (%)
Figure 73 Europe Contrast Agents Market Share, By Country, (2018 V/S 2025) (%)
Figure 74 Germany Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 75 Germany Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 76 Germany Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 77 Germany Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 78 U.K. Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 79 U.K. Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 80 U.K. Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 81 U.K. Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 82 France Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 83 France Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 84 France Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 85 France Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 86 Other European Countries Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 87 Other European Countries Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 88 Other European Countries Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 89 Other European Countries Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 90 Asia-Pacific Contrast Agents Market Share, By Molecule And Iodine Based Contrast Agents Market Share By Ionicity, (2018 V/S 2025) (%)
Figure 91 Asia-Pacific Iodine Based Ionic And Non-Ionic Contrast Agents Market Share By Chemical Structure, (2018 V/S 2025) (%)
Figure 92 Asia-Pacific Gadolinium-Based Contrast Agents Market Share, By Chemical Structure, (2018 V/S 2025) (%) And Macrocyclic, Linear Contrast Agents Market Revenue, By Ionicity, (2018 V/S 2025) ($Mn)
Figure 93 Asia-Pacific Contrast Agents Market Share, By Modality, And Contrast Agents Market Share, By Imaging, (2018 V/S 2025) (%)
Figure 94 Asia-Pacific Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 95 Asia-Pacific Contrast Agents Market Share, By Route Of Administration And End-User, (2018 V/S 2025) (%)
Figure 96 Asia-Pacific Contrast Agents Market Share, By Country, (2018 V/S 2025) (%)
Figure 97 Japan Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 98 Japan Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 99 Japan Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 100 Japan Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 101 China Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 102 China Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 103 China Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 104 China Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 105 Korea Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 106 Korea Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 107 Korea Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 108 Korea Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 109 Other Asia-Pacific Countries Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 110 Other Asia-Pacific Countries Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 111 Other Asia-Pacific Countries Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 112 Other Asia-Pacific Countries Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 113 Rest Of The World Contrast Agents Market Share, By Molecule And Iodine Based Contrast Agents Market Share By Ionicity, (2018 V/S 2025) (%)
Figure 114 Rest Of The World Iodine Based Ionic And Non-Ionic Contrast Agents Market Share By Chemical Structure, (2018 V/S 2025) (%)
Figure 115 Rest Of The World Gadolinium-Based Contrast Agents Market Share, By Chemical Structure, (2018 V/S 2025) (%) And Macrocyclic, Linear Contrast Agents Market Revenue, By Ionicity, (2018 V/S 2025) ($Mn)
Figure 116 Rest Of The World Contrast Agents Market Share, By Modality, And Contrast Agents Market Share, By Imaging, (2018 V/S 2025) (%)
Figure 117 Rest Of The World Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 118 Rest Of The World Contrast Agents Market Share, By Route Of Administration And End-User, (2018 V/S 2025) (%)
Figure 119 Rest Of The World Contrast Agents Market Share, By Country, (2018 V/S 2025) (%)
Figure 120 Brazil Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 121 Brazil Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 122 Brazil Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 123 Brazil Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 124 Rest Of Latam Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 125 Rest Of Latam Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 126 Rest Of Latam Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 127 Rest Of Latam Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 128 Middle East And Others Contrast Agents Market Revenue, By Molecule And By Modality, (2018 V/S 2025) ($Mn)
Figure 129 Middle East And Others Contrast Agents Market Revenue, By Application, (2018) ($Mn)
Figure 130 Middle East And Others Contrast Agents Market Revenue, By Route Of Administration And By Imaging, (2018 V/S 2025) ($Mn)
Figure 131 Middle East And Others Contrast Agents Market Revenue, By End-User, (2018 V/S 2025) ($Mn)
Figure 132 Key Growth Strategies (2016 – 2018)
Figure 133 SWOT: Bayer Group
Figure 134 SWOT: Beijing Beilu Pharmaceutical Co., Ltd.
Figure 135 SWOT: Bracco Group
Figure 136 SWOT: Dongkook Life Science
Figure 137 SWOT: Fujifilm Holding Corporation
Figure 138 SWOT: Fujipharma Co Ltd
Figure 139 SWOT: Ge Healthcare
Figure 140 SWOT: Guerbet
Figure 141 SWOT: Lantheus Medical Imaging Inc.
Figure 142 SWOT: Sanochemia Pharmaceutical Ag
Figure 143 SWOT: Taejoon Pharm Co., Ltd.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alzeca Biosciences, Inc.
  • Bayer Group
  • Beijing Beilu Pharmaceuticals Company Limited
  • Biem İlaç San. And Tic, Inc.
  • Bracco Group
  • Diahan Pharm. Co. Ltd.
  • Dongkook Lifescience
  • Ferric Contrast Company
  • Fujifilm Holding Corporation
  • Fujipharma Co. Ltd
  • GE Company (GE Healthcare)
  • Graton Pharma
  • Guerbet, Llc
  • Harmony Life Sciences
  • IMAX Diagnostic Imaging Limited
  • Inlighta Biosciences, LLC
  • JB Chemicals And Pharmaceuticals Ltd
  • Jodas Expoim Pvt. Ltd
  • Lantheus Medical Imaging
  • Ligand Pharmaceuticals
  • Magnus Health
  • Nano-Therapeutics
  • Rege Imaging & Cinefilms Private Limited
  • Sanochemia Pharmazeutika AG
  • Spago Imaging
  • Stellence Pharmscience Private Limited
  • Taejoon Pharm Co. Ltd.,
  • Trivitron Healthcare
  • Unijules Life Sciences Ltd
  • Unimark Remedies
  • Zhejiang Starry Pharma
Note: Product cover images may vary from those shown
Adroll
adroll